CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published ahead of print on July 23, 2008
Clin J Am Soc Nephrol 3: 1308-1315, 2008
© 2008 American Society of Nephrology
doi: 10.2215/CJN.05501207

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
CJN.05501207v1
3/5/1308    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Visser, F. W.
Right arrow Articles by Navis, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Visser, F. W.
Right arrow Articles by Navis, G.

Clinical Nephrology

Feasibility and Impact of the Measurement of Extracellular Fluid Volume Simultaneous with GFR by 125I-Iothalamate

Folkert W. Visser*, Jaap H. J. Muntinga{dagger}, Rudi A. Dierckx{ddagger}, and Gerjan Navis*

Departments of * Nephrology and {ddagger} Nuclear Medicine, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands; and {dagger} Department of Medical Physiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands

Correspondence: Dr. Folkert W. Visser, University Medical Center Groningen, Department of Internal Medicine, Division of Nephrology, P.O. Box 30.001, 9700 RB Groningen, The Netherlands. Phone: 31-50-3612277; Fax: 31-50-3619310; E-mail: f.visser{at}int.umcg.nl

The feasibility, validity, and possible applications of the assessment of extracellular fluid volume (ECFV) simultaneous with glomerular filtration rate (GFR) were assessed in a series of validation studies using the constant infusion method of 125I-iothalamate (IOT). In 48 subjects with a broad range of GFR, distribution volume (Vd) of IOT corresponded well with Vd bromide (16.71 ± 3.0 and 16.73 ± 3.2 l, respectively, not significant), with a strong correlation (r = 0.933, P < 0.01) and without systematic deviations. Reproducibility assessment in 25 healthy male subjects showed coefficients of variation of 8.6% of duplicate measurement of Vd IOT during strictly standardized (50 mmol Na+/d) sodium intake. An increase in dietary sodium intake (200 mmol Na+/d) induced a corresponding rise in Vd IOT of 1.11 ± 1.5 l (P < 0.01). In 158 healthy prospective kidney donors, the impact of indexing of GFR to ECFV was analyzed. Age, gender, height, and body surface area (BSA) were determinants of GFR. Whereas GFR, GFR/BSA, and GFR/height were gender-dependent, GFR/ECFV was gender-independent and not related to height or BSA. This supports the potential of normalizing GFR by ECFV. Thus, ECFV can be simultaneously assessed with GFR by the constant infusion method using IOT. After appropriate validation, also other GFR tracers could be used for such a simultaneous estimation, providing a valuable resource of data on ECFV in renal studies and, moreover, allowing GFR to be indexed to the body fluid compartment it clears: the ECFV.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Society of Nephrology.